XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY (Unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance, shares at Dec. 31, 2020     13,485,128 (415,328)      
Balance, amount at Dec. 31, 2020 $ (4,161,013) $ 0 $ 13,484 $ (611,854) $ 14,333,285 $ (18,750,824) $ 854,896
Foreign currency translation adjustment, net (473,578) 0 0 $ 0 0 0 (473,578)
Sale of treasury stock to third party, shares       65,000      
Sale of treasury stock to third party, amount 250,000 0 $ 0 $ 650 249,350 0 0
Restricted stock issued to a consultant, shares     1,800,000        
Restricted stock issued to a consultant, amount 1,189,450 0 $ 1,800   1,187,650    
Conversion of notes payable into shares of common stock, shares     781,819        
Conversion of notes payable into shares of common stock, amount 2,564,364 0 $ 782 0 2,563,582 0 0
Net loss (2,173,903) 0 $ 0 $ 0 0 (2,173,903) 0
Balance, shares at Mar. 31, 2021     16,066,947 (350,328)      
Balance, amount at Mar. 31, 2021 (2,804,680) 0 $ 16,066 $ (611,204) 18,333,867 (20,924,727) 381,318
Balance, shares at Dec. 31, 2020     13,485,128 (415,328)      
Balance, amount at Dec. 31, 2020 (4,161,013) 0 $ 13,484 $ (611,854) 14,333,285 (18,750,824) 854,896
Net loss (4,552,959)            
Deemed dividend upon downround of preferred stock and warrants 0            
Stock-based compensation 3,157,450            
Balance, shares at Jun. 30, 2021     16,566,947 (350,328)      
Balance, amount at Jun. 30, 2021 384,548 0 $ 16,566 $ (611,204) 23,901,367 (23,303,783) 381,602
Balance, shares at Mar. 31, 2021     16,066,947 (350,328)      
Balance, amount at Mar. 31, 2021 (2,804,680) 0 $ 16,066 $ (611,204) 18,333,867 (20,924,727) 381,318
Foreign currency translation adjustment, net 284   0 0 0 0 284
Net loss (2,379,056)   $ 0 0 0 (2,379,056) 0
Conversion of related party debt, shares     500,000        
Conversion of related party debt, amount 3,000,000   $ 500 0 2,999,500 0 0
Forgiveness of related party debt 600,000   0 0 600,000 0 0
Restricted stock issued to a consultant 1,968,000   $ 0 $ 0 1,968,000 0 0
Deemed dividend upon downround of preferred stock and warrants 0            
Balance, shares at Jun. 30, 2021     16,566,947 (350,328)      
Balance, amount at Jun. 30, 2021 384,548 0 $ 16,566 $ (611,204) 23,901,367 (23,303,783) 381,602
Balance, shares at Dec. 31, 2021     17,544,509 (387,424)      
Balance, amount at Dec. 31, 2021 4,379,463 0 $ 17,544 $ (816,707) 39,675,753 (34,345,506) (151,621)
Foreign currency translation adjustment, net (405,229) 0 $ 0 0 0 0 (405,229)
Conversion of notes payable into shares of common stock, shares     238,000        
Conversion of notes payable into shares of common stock, amount 973,420 0 $ 238 0 973,182 0 0
Net loss 203,347 0 0 0 0 203,347 0
Adjustements for prior periods from adopting ASU 2020-06 (240,752) $ 0 0 0 (294,000) 53,248 0
Issuance of Series A preferred stock, net of issuance costs of $547,700, shares   6,000          
Issuance of Series A preferred stock, net of issuance costs of $547,700, amount 0 $ 5,452,300 $ 0 0 0 0 0
Cashless exercise of warrants, shares     829,471        
Cashless exercise of warrants, amount 0 $ 0 $ 829 $ 0 (829) 0 0
Balance, shares at Mar. 31, 2022   6,000 18,611,980 (387,424)      
Balance, amount at Mar. 31, 2022 4,910,249 $ 5,452,300 $ 18,611 $ (816,707) 40,354,106 (34,088,911) (556,850)
Balance, shares at Dec. 31, 2021     17,544,509 (387,424)      
Balance, amount at Dec. 31, 2021 4,379,463 $ 0 $ 17,544 $ (816,707) 39,675,753 (34,345,506) (151,621)
Net loss (1,037,909)            
Deemed dividend upon downround of preferred stock and warrants 5,788,493            
Stock-based compensation 24,101            
Balance, shares at Jun. 30, 2022   2,966 23,998,857 (387,424)      
Balance, amount at Jun. 30, 2022 5,130,056 $ 3,024,607 $ 23,997 $ (816,707) 59,861,359 (52,352,868) (1,585,725)
Balance, shares at Mar. 31, 2022   6,000 18,611,980 (387,424)      
Balance, amount at Mar. 31, 2022 4,910,249 $ 5,452,300 $ 18,611 $ (816,707) 40,354,106 (34,088,911) (556,850)
Foreign currency translation adjustment, net (1,028,875) 0 0 0 0 0 (1,028,875)
Net loss (1,241,256) 0 $ 0 0 0 (1,241,256) 0
Cashless exercise of warrants, shares     455,316        
Cashless exercise of warrants, amount 0 $ 0 $ 455 0 (455) 0 0
Conversion of Series A preferred stock, shares   (3,034) 4,892,222        
Conversion of Series A preferred stock, amount 2,427,693 $ (2,427,693) $ 4,892   2,422,801    
Conversion of convertible debt, shares     39,339        
Conversion of convertible debt, amount 38,144 0 $ 39 0 38,105 0 0
Deemed dividend upon downround of preferred stock and warrants 0 0 0 0 16,669,894 (16,669,894) 0
Deemed dividend on preferred stock 0 0 0 0 352,807 (352,807) 0
Stock-based compensation 24,101 $ 0 $ 0 $ 0 24,101 0 0
Balance, shares at Jun. 30, 2022   2,966 23,998,857 (387,424)      
Balance, amount at Jun. 30, 2022 $ 5,130,056 $ 3,024,607 $ 23,997 $ (816,707) $ 59,861,359 $ (52,352,868) $ (1,585,725)